Call Us: 1.800.873.5297

By

Effexor Plaintiffs Seek to Drop 40% of Lawsuits from MDL

Law360 reports that the plaintiffs in a multidistrict litigation involving Effexor, a depression and anxiety medication manufactured by Wyeth Pharmaceuticals Inc., have sought to dismiss 26 lawsuits targeting the Pfizer unit over the drug’s alleged risk of birth defects. The multidistrict litigation is In re: Effexor (Venlafaxine Hydrochloride) Products Liability Litigation, MDL 2458. Judge Cynthia […]

By

Xarelto® Lawsuit Update: Roger Denton Appears on Live Radio Show to Discuss Dangers of Xarelto®

On October 10, 2014, Roger Denton of Schlichter, Bogard & Denton, LLP appeared as a guest on the “Majority Report with Sam Seder” live radio show to discuss Xarelto®, a prescription anticoagulant that is the subject of recent lawsuits in the United States. Click here to listen to the segment. Denton explained that Xarelto® was […]

By

Transvaginal Mesh Lawsuit Update: New Discovery Order Issued in C.R. Bard Litigation Expected to Facilitate Discovery Process

The Honorable Judge Joseph Goodwin, who presides over the C.R. Bard Multidistrict Litigation (MDL 2187), has issued a recent discovery Order with new discovery procedures that will impact the collection and preservation of evidence in the MDL and move the cases forward. In particular, the new discovery Order provides that “discovery in this proceeding may involve […]

By

Kristine Kraft of Schlichter, Bogard & Denton, LLP Reports on the Formation of a New MDL for Claims Alleging Injuries from Testosterone Replacement Therapy Drugs

On June 6, 2014, the Judicial Panel on Multidistrict Litigation (JPML) entered an order (Case MDL No. 2545, Doc No. 211) consolidating all claims filed in federal court alleging injuries involving testosterone products before The Honorable Judge Matthew F. Kennerly in the United States District Court for the Northern District of Illinois in an MDL […]

By

Mirena® IUD Lawsuit Update: Number of Cases Filed Continues to Grow in MDL 2434

According to a recent report, lawsuits are continuing to be filed against Bayer Corporation, the maker of the Mirena® intrauterine device, alleging that women haven’t been adequately warned of the potentially serious health risks associated with the device. The number of Mirena® lawsuits continues to grow with 528 lawsuits currently on file in federal court […]

By

$830 Million Settlement Reached in Endo and American Medical Systems Transvaginal Mesh Litigation

Reuters reports that a settlement in the amount of $830 Million has been reached to resolve legal claims from women who allege to have been injured by transvaginal mesh devices manufactured by Endo and American Medical Systems. Endo (although not admitting liability or fault) released a statement indicating that the settlement agreement will provide compensation […]

By

ABC Detroit Reports: “Pradaxa is the Most Complained about Drug in the United States”

ABC Detroit reports that Pradaxa is the most complained about drug in the United States. Since its approval by the FDA in 2010, Pradaxa has been associated with 1,158 deaths and 12,494 serious injuries in the United States, according to Tom Moore , senior scientist for drug safety and policy at the Institute for Safe […]

By

TVM Lawsuit Update: 1.2 Million Verdict Against Johnson & Johnson’s Ethicon® Transvaginal Mesh

Bloomberg reports that a Texas jury has rendered a verdict in favor of a woman who alleged one of the company’s Ethicon® transvaginal mesh products was defectively designed and caused her injuries. The jury ordered the manufacturer of the transvaginal mesh product, Johnson & Johnson, to pay $1.2 million dollars in damages. The Texas case […]

By

Actos® MDL Trial Update: Jury Awards Plaintiff $9 Billion in Punitive Damages

The first federal Actos® trial in the MDL concluded on Monday, April 7th. After deliberations, the jury awarded the plaintiff $1.5 million in compensatory damages and $9 billion in punitive damages ($6 billion against Takeda; $3 billion against Eli Lilly). The first trial in the Multidistrict Litigation In re: Actos® (Pioglitazone) Products Liability Litigation (MDL […]

By

Transvaginal Mesh Plaintiffs Ask Justice Department to Investigate Destruction of Evidence Claims Against Johnson & Johnson

USA Today reports that plaintiffs who have alleged injuries from Ethicon® transvaginal mesh products – manufactured by Johnson & Johnson – have urged the Justice Department to investigate claims that the manufacturer has intentionally destroyed documents. The article describes that the nonprofit organization Corporate Action Network has asked Attorney General Eric Holder to investigate whether […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.